Myriad Genetics Inc Stock (MYGN) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 6.29%202.70 | 190.70 | 200.40 | 209.80 | 205.70 |
| Cost Of Revenue | 2.04%65.00 | 63.70 | 62.80 | 63.00 | 61.90 |
| Gross Profit | 8.43%137.70 | 127.00 | 137.60 | 146.80 | 143.80 |
7.05%177.60 | 165.90 | 168.30 | 152.50 | 167.10 | |
| Research and Development | 6.00%26.50 | 25.00 | 27.10 | 25.50 | 28.20 |
| Depreciation and Amortization | 0.80%12.60 | 12.50 | 12.50 | 12.60 | 12.60 |
| Operating Income/Loss | 2.57%-39.90 | -38.90 | -30.70 | -5.70 | -23.30 |
| Nonoperating Income/Loss | -3.70 | -3.70 | -3.40 | -3.20 | -2.90 |
| Income/Loss From Continuing Operations Before Tax | 2.35%-43.60 | -42.60 | -34.10 | -8.90 | -26.20 |
| Income Tax Expense/Benefit | 50.00%0.30 | 0.60 | - | -1.00 | 1.20 |
1.62%-43.90 | -43.20 | -34.10 | -7.90 | -27.40 | |
| Attributable To Parent | 1.62%-43.90 | -43.20 | -34.10 | -7.90 | -27.40 |
| Basic Average Shares | 0.95%95.70 | 94.80 | 93.70 | 0.30 | 93.10 |
| Diluted Average Shares | 0.95%95.70 | 94.80 | 93.70 | 0.30 | 93.10 |
| Basic Earnings Per Share | -0.46 | -0.46 | -0.36 | -0.07 | -0.29 |
| Diluted Earnings Per Share | -0.46 | -0.46 | -0.36 | -0.07 | -0.29 |